A SPRY2 mutation leading to MAPK/ERK pathway inhibition is associated with an autosomal dominant form of IgA nephropathy.

Eugenio Sangiorgi, Fiorella Gurrieri, Annamaria Milillo, Francesca La Carpia, Stefano Costanzi, Maurizio Martini, Luigi Maria Larocca, Gisella Vischini

Research output: Contribution to journal › Article › peer-review

7 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A SPRY2 mutation leading to MAPK/ERK pathway inhibition is associated with an autosomal dominant form of IgA nephropathy.'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology